Rafi Kabarriti
Montefiore Medical Center, Albert Einstein College of Medicine
Papers
2
Total Citations
59
H-Index
2
About
Rafi Kabarriti is a radiation oncologist whose research centers on head and neck cancers, with a particular focus on optimizing treatment strategies for oropharyngeal squamous cell carcinoma. His work critically examines the intersection of surgical innovation and adjuvant therapy, especially regarding Transoral Robotic Surgery (TORS). In a landmark 2018 study (50 citations), Kabarriti demonstrated that TORS can significantly impact survival outcomes and reduce the need for chemotherapy in appropriately selected patients, offering a less toxic treatment pathway. Earlier, in a 2013 study (9 citations), he provided crucial insights into the risks of omitting adjuvant radiotherapy after TORS, specifically identifying an increased risk of retropharyngeal node recurrence—a finding that has informed clinical decision-making about post-surgical radiation fields. Kabarriti’s contributions bridge surgical oncology and radiation oncology, helping to define evidence-based, de-escalation protocols that spare patients unnecessary toxicity while maintaining oncologic control. His work continues to shape how multidisciplinary teams approach organ-preserving treatments for head and neck cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2